NCT06887244 Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity
| NCT ID | NCT06887244 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cancer Institute, Naples |
| Condition | Patient Satisfaction and Efficacy of Bowel-preparation |
| Study Type | INTERVENTIONAL |
| Enrollment | 534 participants |
| Start Date | 2024-06-24 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 534 participants in total. It began in 2024-06-24 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a multicenter, non-pharmacological, experimental, prospective, randomized study, with two arms (1:1) in a single-blind design. The study aims to evaluate the effectiveness of a tele-consultation procedure in patients undergoing elective colonoscopy in terms of quality of the exam, anxiety procedure-related and financial toxicity.
Eligibility Criteria
Inclusion Criteria: Subjects eligible for outpatient pancolonoscopy: * for diagnostic purposes; * for screening purposes; * for post-polypectomy follow-up; * of both genders; * of all ethnicities; Exclusion Criteria: * Patients under 18 years of age or over 80 years of age; * Patients on waiting lists with SHORT priority: the procedure to be provided within a short time (no more than 10 days); * Patients included in GOM pathways who undergo colonoscopy within 10 days; * Pregnancy; * Presence of known contraindications to bowel preparation; * Presence of known contraindications to performing pancolonoscopy; * Patients who have undergone colonic resection and/or have a colostomy/ileostomy; * Patients with cognitive impairments; * Patients declared legally incompetent or unable to understand and make decisions; * Patients unable to provide informed consent.
Contact & Investigator
Francesco De Falco, Nursing degree
PRINCIPAL INVESTIGATOR
National Cancer Institute, IRCCS Fondazione G. Pascale
Frequently Asked Questions
Who can join the NCT06887244 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Patient Satisfaction and Efficacy of Bowel-preparation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06887244 currently recruiting?
Yes, NCT06887244 is actively recruiting participants. Contact the research team at endoscopia@istitutotumori.na.it for enrollment information.
Where is the NCT06887244 trial being conducted?
This trial is being conducted at Naples, Italy.
Who is sponsoring the NCT06887244 clinical trial?
NCT06887244 is sponsored by National Cancer Institute, Naples. The principal investigator is Francesco De Falco, Nursing degree at National Cancer Institute, IRCCS Fondazione G. Pascale. The trial plans to enroll 534 participants.